These medications typically require indefinite use for weight management effectiveness
USA 104 , 1506915074 (2007)
July 31 Product: Johnson & Johnsons Darzalex Faspro Indication : Multiple myeloma Johnson & Johnson picked up another indication for its Darzalex Faspro Wednesday as the FDA approved the therapy, in combination with bortezomib, lenalidomide and dexamethasone, to treat newly diagnosed multiple myeloma patients who are eligible for autologous stem cell transplant
About this article Cite this article Karacabeyli, D., Lacaille, D
The dose of alogliptin was based on estimated renal function at baseline per dosage and administration recommendations [see Dosage and Administration (2.3)]
Glucagon-like peptide-1 (GLP-1) receptor agonistsmedications originally developed for type 2 diabetesare emerging as a potential treatment option for PCOS due to their effects on insulin sensitivity, weight management, and hormonal regulation